Comparison of CEF (C: cyclophosphamide, E: epirubicin, and 5FU) and EC (E: epirubicin and C: cyclophosphamide) therapy in neoadjuvant setting for axillary lymph node metastasis-positive breast cancer.

CINCINNATI — A Christ Hospital patient is giving back by expanding access to cool cap therapy for cancer patients. Francie Pepper, 83, was diagnosed with cancer 3 years ago. Pepper used a new cooling ...

(WXYZ) — Keeping your hair during some of life’s most challenging times and allowing positive self-esteem, privacy, and confidence can be difficult at times ...

To help prevent hair loss for eligible breast-cancer patients in chemotherapy, Mount Sinai South Nassau Breast Health Services is now offering cold-cap therapy. Cold-cap therapy was cleared by the U.S ...

Add Yahoo as a preferred source to see more of our stories on Google. VENICE – Shortly after Hollie Mowry learned she had breast cancer last July, she and her husband Tony took their daughters Cecelia ...

Melissa Lisbon steeled herself for the nausea and bone pain tied to chemotherapy after being diagnosed with breast cancer. The possible loss of her shoulder-length blond hair, though, made her anxious ...

COLUMBUS, Ohio — No one wants to hear the words, “You have cancer.” A diagnosis can come with fear, anger, sadness and lots of questions. If chemotherapy is prescribed, the question of hair loss is ...

JACKSONVILLE, Fla. — Aside from skin cancer, breast cancer is the most common cancer in women in the U.S. About 240,000 women will be diagnosed with breast cancer this year in the U.S. alone according ...

Clarification: Both the Dignitana and Paxman scalp cooling systems have FDA clearance. The FDA does not have an approval track for such devices. An earlier version of this story said otherwise. VENICE ...